NGM·Healthcare·$1.2B·#387 / 520 in Healthcare
EYPT EyePoint, Inc.
30HIGH RISK
CATEGORY BREAKDOWN
GROWTH0
QUALITY60
STABILITY37
VALUATION0
GOVERNANCE22
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
-27.5%
0
> 50% strong
Gross Margin
Revenue retained after direct costs
93.4%
100
> 50% strong
Cash Runway
Months of cash at current burn rate
5 months
8
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
6.8%
95
< 25% strong
Price / Sales
Market cap relative to trailing revenue
37.0x
0
< 3x strong
Rule of 40
Growth rate plus operating margin
-803
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
3.7%
29
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+21.8%
8
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE EYPT WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when EYPT's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.